APA (7th ed.) Citation

PA, S., B, R., NP, S., JK, G., A, M., SR, P., . . . VGM, N. (2026). Targeting PIP5K ameliorates hepatic cancer by inhibiting PI3K/AKT and the autophagy mechanism and enhancing ROS-mediated apoptosis. Frontiers in pharmacology, 17, 1791462. https://doi.org/10.3389/fphar.2026.1791462

Chicago Style (17th ed.) Citation

PA, Shantanu, et al. "Targeting PIP5K Ameliorates Hepatic Cancer by Inhibiting PI3K/AKT and the Autophagy Mechanism and Enhancing ROS-mediated Apoptosis." Frontiers in Pharmacology 17 (2026): 1791462. https://doi.org/10.3389/fphar.2026.1791462.

MLA (9th ed.) Citation

PA, Shantanu, et al. "Targeting PIP5K Ameliorates Hepatic Cancer by Inhibiting PI3K/AKT and the Autophagy Mechanism and Enhancing ROS-mediated Apoptosis." Frontiers in Pharmacology, vol. 17, 2026, p. 1791462, https://doi.org/10.3389/fphar.2026.1791462.